share_log

Inovio Pharmaceuticals analyst ratings

Benzinga Analyst Ratings ·  Mar 23, 2021 20:24
DateResearch FirmActionCurrentPT
3/23/21B of A SecuritiesInitiates Coverage OnNeutral13.0
2/12/21OppenheimerInitiates Coverage OnOutperform35.0
11/17/20Roth CapitalDowngradesSell8.0
11/10/20Roth CapitalUpgradesNeutral
9/28/20Cantor FitzgeraldDowngradesNeutral12.0
9/28/20Maxim GroupUpgradesBuy20.0
7/01/20Maxim GroupDowngradesHold
6/29/20HC Wainwright & Co.DowngradesNeutral
6/26/20Cantor FitzgeraldMaintainsOverweight45.0
6/26/20StifelDowngradesHold24.0
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment